Pakistan Institute of Learning and Living - Recruiting 18 years to 35 years. - A Randomised Double Blind Placebo Controlled 12 Week Trial of Methotrexate Added to Treatment As Usual in Early Schizophrenia.
University of North Carolina, Chapel Hill - Recruiting 18 years or older. - Clinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia.
National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years. - Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography.
Luye Pharma Group Ltd. - Recruiting 18 years to 65 years. - An Open-Label, Single Ascending Dose Pharmacokinetic and Safety Study of LY03004 Following Escalating Single Intramuscular Injection in Stable Patients With Schizophrenia or Schizoaffective Disorder.
Heinrich-Heine University, Duesseldorf - Recruiting 18 years to 65 years. - A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE.
Olanzapine; Amisulpride; Olanzapine and Amisulpride
Technische Universitt Mnchen - Recruiting 18 years to 65 years. - The Switch Study - Efficacy of Early Antipsychotic Switch Versus Maintenance in Patients With Schizophrenia Poorly Responding to Two Weeks of Antipsychotic Treatment.
Centre for Addiction and Mental Health - Recruiting 18 years to 59 years. - Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Working Memory Deficits in Schizophrenia and Effects on Brain Structure.
National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 50 years. - Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype.
Vanderbilt University - Recruiting 18 years to 65 years. - High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable.
long-acting injectable risperidone; long acting injectable risperidone